These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 3262664)
1. Impairment of in vitro natural antibacterial activity in HIV-infected patients. Tagliabue A; Nencioni L; Mantovani A; Lazzarin A; Villa L; Romano M; Rossini S; Foppa CU; Fanetti G; Masello LC J Immunol; 1988 Oct; 141(8):2607-11. PubMed ID: 3262664 [TBL] [Abstract][Full Text] [Related]
2. Natural antibacterial activity against Salmonella typhi in human cord blood. Romano M; de Magistris MT; Villa L; Nuti S; de Leo V; Boraschi D; Nencioni L; Tagliabue A J Immunol; 1989 Apr; 142(7):2513-8. PubMed ID: 2926143 [TBL] [Abstract][Full Text] [Related]
3. Natural anti-bacterial activity against Salmonella typhi by human T4+ lymphocytes armed with IgA antibodies. Tagliabue A; Villa L; Boraschi D; Peri G; de Gori V; Nencioni L J Immunol; 1985 Dec; 135(6):4178-82. PubMed ID: 3934277 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity. Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988 [TBL] [Abstract][Full Text] [Related]
5. Deficient natural-cell mediated immunity against "Salmonella typhi" in patients with LAS and AIDS. Nencioni L; Villa L; Poli G; Mantovani A; Lazzarin A; Fanetti G; Masello LC; Tagliabue A Ann Sclavo Collana Monogr; 1986; 3(1-2):99-102. PubMed ID: 3426884 [No Abstract] [Full Text] [Related]
6. IgA-driven T cell-mediated anti-bacterial immunity in man after live oral Ty 21a vaccine. Tagliabue A; Villa L; De Magistris MT; Romano M; Silvestri S; Boraschi D; Nencioni L J Immunol; 1986 Sep; 137(5):1504-10. PubMed ID: 3489034 [TBL] [Abstract][Full Text] [Related]
7. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages. Ljunggren K; Böttiger B; Biberfeld G; Karlson A; Fenyö EM; Jondal M J Immunol; 1987 Oct; 139(7):2263-7. PubMed ID: 3498755 [TBL] [Abstract][Full Text] [Related]
8. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). Shearer GM; Bernstein DC; Tung KS; Via CS; Redfield R; Salahuddin SZ; Gallo RC J Immunol; 1986 Oct; 137(8):2514-21. PubMed ID: 3489767 [TBL] [Abstract][Full Text] [Related]
9. Cellular immunity against Salmonella typhi after live oral vaccine. Tagliabue A; Nencioni L; Caffarena A; Villa L; Boraschi D; Cazzola G; Cavalieri S Clin Exp Immunol; 1985 Nov; 62(2):242-7. PubMed ID: 3878744 [TBL] [Abstract][Full Text] [Related]
10. Antibody-dependent cellular cytotoxicity by polymorphonuclear leucocytes in patients with AIDS and AIDS-related complex. Kinne TJ; Gupta S J Clin Lab Immunol; 1989 Dec; 30(4):153-6. PubMed ID: 2642173 [TBL] [Abstract][Full Text] [Related]
11. The immunologic aspects of human immunodeficiency virus infection in the gastrointestinal tract. Schneider T; Ullrich R; Zeitz M Semin Gastrointest Dis; 1996 Jan; 7(1):19-29. PubMed ID: 8903576 [TBL] [Abstract][Full Text] [Related]
12. AIDS and lymphadenopathy syndrome (LAS) patients display similar abnormal in vitro proliferation and differentiation of T-colony forming cells (T-CFC). Lunardi Iskandar Y; Georgoulias V; Rozenbaum W; Vittecoq D; Meyer P; Gentilini M; Jasmin C Cancer Detect Prev Suppl; 1987; 1():525-33. PubMed ID: 3500783 [TBL] [Abstract][Full Text] [Related]
13. Anti-class II antibodies in AIDS patients and AIDS-risk groups. de la Barrera S; Fainboim L; Lugo S; Picchio GR; Muchinik GR; de Bracco MM Immunology; 1987 Dec; 62(4):599-604. PubMed ID: 3501399 [TBL] [Abstract][Full Text] [Related]
14. Natural and antibody-dependent cell-mediated activity against Salmonella typhimurium by peripheral and intestinal lymphoid cells in mice. Nencioni L; Villa L; Boraschi D; Berti B; Tagliabue A J Immunol; 1983 Feb; 130(2):903-7. PubMed ID: 6336774 [TBL] [Abstract][Full Text] [Related]
16. Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects. Goh WC; Markee J; Akridge RE; Meldorf M; Musey L; Karchmer T; Krone M; Collier A; Corey L; Emerman M; McElrath MJ J Infect Dis; 1999 Mar; 179(3):548-57. PubMed ID: 9952360 [TBL] [Abstract][Full Text] [Related]
17. Interleukin (IL)-2 deficiency aggravates the defect of natural killer cell activity in AIDS patients. Zerhouni B; Sanhadji K; Kehrli L; Livrozet JM; Touraine JL Thymus; 1997; 24(3):147-56. PubMed ID: 9151380 [TBL] [Abstract][Full Text] [Related]
18. Abnormalities of the intestinal immune system in AIDS. Rodgers VD; Kagnoff MF Gastroenterol Clin North Am; 1988 Sep; 17(3):487-94. PubMed ID: 3049357 [TBL] [Abstract][Full Text] [Related]
19. T-lymphocytopaenia, opportunistic infections and pathological findings in Ghanaian AIDS patients and their sexual partners. Ayisi NK; Wiredu EK; Sata T; Nyadedzor C; Tsiagbe VK; Newman M; Cofie CN; Taneguchi K East Afr Med J; 1997 Dec; 74(12):784-91. PubMed ID: 9557423 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans. Sztein MB; Tanner MK; Polotsky Y; Orenstein JM; Levine MM J Immunol; 1995 Oct; 155(8):3987-93. PubMed ID: 7561107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]